Pharmaceutical Care for Asthma Control Improvement (PHARMACI)-Study

University Ghent

Status: Completed

Conditions: Asthma

Treatments: Procedure: Pharmaceutical care for asthma patients

Study type: Interventional

Funder types: Other

Identifiers

NCT00263159

2005/320

Details and patient eligibility

About

The objective of this study is to evaluate the therapeutic effectiveness and cost-effectivity of pharmaceutical care for asthma patients.

Full description

The objective of this study is to evaluate the therapeutic effectiveness and cost-effectivity of pharmaceutical care for asthma patients. Patients will be randomly allocated to the control group (= no input from pharmacist) or intervention group (= with pharmaceutical care at baseline and follow-up visits over 6 months).

Enrollment: 221 patients

Sex: All

Ages: 18 to 50 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients with persistent asthma
• Asthma treatment for at least 12 months
• Regular visitors of the participating community pharmacy

Exclusion criteria

• Severe co-morbidity
• > 10 pack-years smoking history
• Asthma Control Test score < 15 or =25